ID   CMS
AC   CVCL_H248
DR   Cosmic; 996322
DR   Cosmic; 1037674
DR   Cosmic; 2089660
DR   DSMZ; ACC-985
DR   Wikidata; Q54813813
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10674912;
RX   PubMed=14504097;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Doubling time: 42 hours (DOI=10.1016/B978-0-12-221970-2.50457-5); ~48 hours (DSMZ=ACC-985).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-985
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 15,16
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 18,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 11,14
ST   FGA: 21,23
ST   Penta D: 9,10
ST   Penta E: 13,18
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,15
DI   NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
RX   PubMed=23955599; DOI=10.1038/ng.2731;
RA   Kon, Ayana
RA   Shih, Lee-Yung
RA   Minamino, Masashi
RA   Sanada, Masashi
RA   Shiraishi, Yuichi
RA   Nagata, Yasunobu
RA   Yoshida, Ken-ichi
RA   Okuno, Yusuke
RA   Bando, Masashige
RA   Nakato, Ryuichiro
RA   Ishikawa, Shumpei
RA   Sato-Otsubo, Aiko
RA   Nagae, Genta
RA   Nishimoto, Aiko
RA   Haferlach, Claudia
RA   Nowak, Daniel
RA   Sato, Yusuke
RA   Alpermann, Tamara
RA   Nagasaki, Masao
RA   Shimamura, Teppei
RA   Tanaka, Hiroko
RA   Chiba, Kenichi
RA   Yamamoto, Ryo
RA   Yamaguchi, Tomoyuki
RA   Otsu, Makoto
RA   Obara, Naoshi
RA   Sakata-Yanagimoto, Mamiko
RA   Nakamaki, Tsuyoshi
RA   Ishiyama, Ken
RA   Nolte, Florian
RA   Hofmann, Wolf-Karsten
RA   Miyawaki, Shuichi
RA   Chiba, Shigeru
RA   Mori, Hiraku
RA   Nakauchi, Hiromitsu
RA   Koeffler, Harold Phillip
RA   Aburatani, Hiroyuki
RA   Haferlach, Torsten
RA   Shirahige, Katsuhiko
RA   Miyano, Satoru
RA   Ogawa, Seishi
RT   "Recurrent mutations in multiple components of the cohesin complex in
RT   myeloid neoplasms.";
RL   Nat. Genet. 45:1232-1237(2013).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=10674912; DOI=10.3109/10428190009148861;
RA   Sato, Takeyuki
RA   Sekine, Hiromasa
RA   Kakuda, Harumi
RA   Miura, Nobuyuki
RA   Sunohara, Masataka
RA   Fuse, Akira
RT   "HIV infection of megakaryocytic cell lines.";
RL   Leuk. Lymphoma 36:397-404(2000).
//
RX   PubMed=14504097; DOI=10.1182/blood-2003-02-0418;
RA   Taketani, Takeshi
RA   Taki, Tomohiko
RA   Sugita, Kanji
RA   Furuichi, Yoshiyuki
RA   Ishii, Eiichi
RA   Hanada, Ryoji
RA   Tsuchida, Masahiro
RA   Sugita, Kenichi
RA   Ida, Kohmei
RA   Hayashi, Yasuhide
RT   "FLT3 mutations in the activation loop of tyrosine kinase domain are
RT   frequently found in infant ALL with MLL rearrangements and pediatric
RT   ALL with hyperdiploidy.";
RL   Blood 103:1085-1088(2004).
//